Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 54.94

-0.3%

11:08 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jacob Snyder who wrote (7742)	1/16/2003 2:30:53 PM
From: Biomaven	Read Replies (2) of 52153

A forecast from BofA that I saw today predicts expected 2005 earnings for the "big 9" biotechs will be almost double 2002 earnings. 5 year forecast CAGR is a shade under 20%. I think that there is not much risk in the three year forecast, which is a lot more than you can say for most sectors. In the short term, however, the first quarter has historically been the weakest quarter for biotech. I agree that the overall market remains at risk. Although I have closed out most of my biotech hedges, I have also used the last few month's strength in biotech to come completely off margin (and then some) and I retain a short on the QQQ as a hedge. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next